Faculty
-
August 13, 2014
On ABC News, Robert Klitzman Explores the Ethics of New Ebola Treatment
Although the World Health Organization has approved the new, experimental Ebola medication ZMapp, the limited supply of the drug raises questions about which patients should be prioritized for treatment.
ABC News said, "ZMapp...has notably not been supplied to the Africans who make up the majority of victims."
Bioethics director Robert Klitzman commented, "We want to make sure that we have clear criteria to make sure that it's done fairly."
Faculty, In the Media
Kiran Bhujle, Global Managing Director at SVAM International and part-time lecturer in M.S. in Enterprise Risk Management and M.S. Technology Management programs, explores how AI is reshaping who gets to build technology.
(Forbes)
Faculty
In Columbia’s Nonprofit Management program, lecturers Ramone Segree and John Hicks share real-world insights on building impactful careers in today’s evolving nonprofit sector.
Faculty
Cuts to the U.S. Forest Service weaken science, staffing, and oversight, leaving forests more vulnerable to harm and misuse.
All News
